Amexdrug Corporation (AXRX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 3.91 Million | 4.82 Million | 6.36 Million | 7.72 Million | 10.5 Million | 10.42 Million |
| Cost of Revenue | 2.88 Million | 3.82 Million | 4.81 Million | 6.23 Million | 8.77 Million | 8.46 Million |
| Gross Profit | 1.03 Million | 995.15 Thousand | 1.55 Million | 1.48 Million | 1.73 Million | 1.96 Million |
| Operating Expenses | 917.86 Thousand | 858.71 Thousand | 1.24 Million | 1.2 Million | 1.48 Million | 1.74 Million |
| Selling, General and Administrative Expenses | 877.69 Thousand | 780.34 Thousand | 1.15 Million | 1.07 Million | 1.39 Million | 1.67 Million |
| Research and Development Expenses | - | - | 18.1 Thousand | 75.14 Thousand | 92.28 Thousand | 69.2 Thousand |
| Other Expenses | 40.17 Thousand | -78.37 Thousand | -67.16 Thousand | -54.38 Thousand | - | - |
| Cost and Expenses | 3.79 Million | 4.68 Million | 6.05 Million | 7.44 Million | 10.25 Million | 10.21 Million |
| Operating Income | 117.12 Thousand | 136.45 Thousand | 314.72 Thousand | 280.07 Thousand | 249.12 Thousand | 214.62 Thousand |
| Interest Expense | 81.29 Thousand | 58.2 Thousand | 118.72 Thousand | 63.17 Thousand | 47.71 Thousand | 51.25 Thousand |
| Income Tax Expense | -167.89 Thousand | -236.55 Thousand | 1.17 | -4.44 | 1.83 | 56.77 Thousand |
| Earnings before Tax | 35.83 Thousand | 74.19 Thousand | 195.99 Thousand | 216.89 Thousand | 201.39 Thousand | 168.13 Thousand |
| Net Income | 35.83 Thousand | 74.19 Thousand | 195.99 Thousand | 216.89 Thousand | 201.39 Thousand | 111.36 Thousand |
| Earnings Per Share Basic | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share Diluted | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Average Shares Outstanding | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million |
| Gross Margin | 0.26 | 0.21 | 0.24 | 0.19 | 0.17 | 0.19 |
| EBIT Margin | 0.03 | 0.03 | 0.05 | 0.04 | 0.02 | 0.02 |
| Profit Margin | 0.01 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 |
| EBITDA | 117.13 Thousand | 132.39 Thousand | 314.71 Thousand | 281.01 Thousand | 252.85 Thousand | 226.8 Thousand |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.05 | 0.04 | 0.02 | 0.02 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 836.37 Thousand | 956.17 Thousand | 955.07 Thousand | 3.91 Million | 949.61 Thousand | 1.09 Million |
| Cost of Revenue | 522.01 Thousand | 557.87 Thousand | 662.76 Thousand | 2.88 Million | 722.88 Thousand | 752.63 Thousand |
| Gross Profit | 314.35 Thousand | 398.29 Thousand | 292.31 Thousand | 1.03 Million | 226.73 Thousand | 339.61 Thousand |
| Operating Expenses | 270.45 Thousand | 345.56 Thousand | 245.94 Thousand | 917.86 Thousand | 274.77 Thousand | 299.22 Thousand |
| Selling, General and Administrative Expenses | 257.47 Thousand | 344.93 Thousand | 232.87 Thousand | - | 267.16 Thousand | 270.53 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -12.98 Thousand | -630.00 | -13.07 Thousand | -40.17 Thousand | -7610.00 | -28.69 Thousand |
| Cost and Expenses | 792.47 Thousand | 903.43 Thousand | 908.7 Thousand | 3.79 Million | 997.65 Thousand | 1.05 Million |
| Operating Income | 43.9 Thousand | 52.73 Thousand | 46.37 Thousand | 117.13 Thousand | -48.05 Thousand | 40.39 Thousand |
| Interest Expense | 28.57 Thousand | 29.26 Thousand | 16.13 Thousand | 81.29 Thousand | 19.42 Thousand | 18.33 Thousand |
| Income Tax Expense | - | -43.27 Thousand | -43.81 Thousand | -167.89 Thousand | 39.58 Thousand | -122.08 Thousand |
| Earnings before Tax | 15.32 Thousand | 23.47 Thousand | 30.23 Thousand | 35.83 Thousand | -67.46 Thousand | 22.05 Thousand |
| Net Income | 15.32 Thousand | 23.47 Thousand | 30.23 Thousand | 35.83 Thousand | -67.46 Thousand | 22.05 Thousand |
| Earnings Per Share Basic | 0.00 | 0.00 | 0.00 | - | -0.00 | 0.00 |
| Earnings Per Share Diluted | 0.00 | 0.00 | 0.00 | - | -0.00 | 0.00 |
| Weighted Average Shares Outstanding | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million | 169.4 Million |
| Gross Margin | 0.38 | 0.42 | 0.31 | 0.26 | 0.24 | 0.31 |
| EBIT Margin | 0.05 | 0.06 | 0.05 | - | -0.05 | 0.04 |
| Profit Margin | 0.02 | 0.02 | 0.03 | 0.01 | -0.07 | 0.02 |
| EBITDA | 43.9 Thousand | 52.73 Thousand | 46.37 Thousand | - | -48.05 Thousand | 40.39 Thousand |
| Earnings Before Tax Margin | 0.05 | 0.06 | 0.05 | 0.03 | -0.05 | 0.04 |
1429
2355
9763
NTG
1430
PPSI